Article thumbnail

Anesthetic Propofol Reduces Endotoxic Inflammation by Inhibiting Reactive Oxygen Species-regulated Akt/IKKβ/NF-κB Signaling

By Chung-Hsi Hsing, Ming-Chung Lin, Pui-Ching Choi, Wei-Ching Huang, Jui-In Kai, Cheng-Chieh Tsai, Yi-Lin Cheng, Chia-Yuan Hsieh, Chi-Yun Wang, Yu-Ping Chang, Yu-Hong Chen, Chia-Ling Chen and Chiou-Feng Lin
Topics: Research Article
Publisher: Public Library of Science
OAI identifier: oai:pubmedcentral.nih.gov:3050912
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2009). Aging and animal models of systemic insult: trauma, burn, and sepsis.
  2. (2005). Antiinflammatory and antioxidative effects of propofol on lipopolysaccharideactivated macrophages.
  3. (2009). Antioxidant therapy in critically septic patients.
  4. (2008). Combined effects of propofol and dexamethasone on rats with endotoxemia.
  5. (2005). Dose effects of propofol on hemodynamic and cytokine responses to endotoxemia in rats.
  6. (2002). Effects of intravenous anesthetics on interleukin (IL)-6 and IL-10 production by lipopolysaccharide-stimulated mononuclear cells from healthy volunteers.
  7. (2003). Effects of ketamine and propofol on the ratio of interleukin-6 to interleukin-10 during endotoxemia in rats.
  8. (2005). Effects of post-treatment with low-dose propofol on inflammatory responses to lipopolysaccharideinduced shock in conscious rats.
  9. (2004). Effects of propofol on endotoxin-induced acute lung injury in rabbit.
  10. (2009). Effects of propofol on pro-inflammatory cytokines and nuclear factor kappaB during polymicrobial sepsis in rats.
  11. (2008). Experimental models of sepsis and their clinical relevance.
  12. (2009). Glycogen synthase kinase-3 negatively regulates anti-inflammatory interleukin-10 for lipopolysaccharide-induced iNOS/NO biosynthesis and RANTES production in microglial cells.
  13. (2007). GSK-3beta acts downstream of PP2A and the PI 3-kinase-Akt pathway, and upstream of caspase-2 in ceramide-induced mitochondrial apoptosis.
  14. (2006). Halothane induces oxidative stress and NF-kappaB activation in rat liver: protective effect of propofol.
  15. (2003). IKK beta plays an essential role in the phosphorylation of RelA/p65 on serine 536 induced by lipopolysaccharide.
  16. (2001). Impaired pulmonary NF-kappaB activation in response to lipopolysaccharide in NADPH oxidase-deficient mice.
  17. (2004). Involvement of reactive oxygen species in Toll-like receptor 4-dependent activation of NFkappa B.
  18. (2001). Lipopolysaccharide induces Rac1-dependent reactive oxygen species formation and coordinates tumor necrosis factor-alpha secretion through IKK regulation of NF-kappa B.
  19. (2003). Novel strategies for the treatment of sepsis.
  20. (2003). Novel therapeutic strategies based on toll-like receptor signaling.
  21. (2003). Oxidative stress and gene expression in sepsis.
  22. (2009). Oxidative stress and mitochondrial dysfunction in sepsis: a potential therapy with mitochondria-targeted antioxidants.
  23. (2002). Oxygen-sensitive pro-inflammatory cytokines, apoptosis signaling and redox-responsive transcription factors in development and pathophysiology.
  24. (2003). Phosphatidylinositol 3-kinase is involved in Toll-like receptor 4-mediated cytokine expression in mouse macrophages.
  25. (1987). Propofol for intravenous sedation.
  26. (2010). Propofol has anti-inflammatory effects on alveolar type II epithelial cells.
  27. (2010). Propofol increases bone morphogenetic protein-7 and decreases oxidative stress in sepsis-induced acute kidney injury. Nephrol Dial Transplant.
  28. (2009). Propofol infusion syndrome: update of clinical manifestation and pathophysiology.
  29. (2009). Propofol inhibits cyclooxygenase activity in human monocytic THP-1 cells.
  30. (2009). Propofol inhibits lipoteichoic acid-induced iNOS gene expression in macrophages possibly through downregulation of toll-like receptor 2-mediated activation of Raf-MEK1/2-ERK1/2-IKK-NFkappaB.
  31. (2008). Propofol pretreatment attenuates LPS-induced granulocyte-macrophage colony-stimulating factor production in cultured hepatocytes by suppressing MAPK/ERK activity and NF-kappaB translocation.
  32. (2009). Propofol suppresses tumor necrosis factor-alpha biosynthesis in lipopolysaccharide-stimulated macrophages possibly through downregulation of nuclear factor-kappa B-mediated toll-like receptor 4 gene expression.
  33. (2005). Propofol: an immunomodulating agent.
  34. (2008). Protective effects of propofol on acute lung injury induced by oleic acid in conscious rats.
  35. (2006). Regulation and function of IKK and IKK-related kinases. Sci STKE
  36. (2006). Tanshinone IIA inhibits LPS-induced NF-kappaB activation
  37. (2008). The non-provitamin A carotenoid, lutein, inhibits NF-kappaB-dependent gene expression through redox-based regulation of the phosphatidylinositol 3-kinase/PTEN/Akt and NFkappaB-inducing kinase pathways: role of H(2)O(2) in NF-kappaB activation.
  38. (2003). The pathophysiology of propofol infusion syndrome: a simple name for a complex syndrome.